annual review

Shire Issues 2016 Annual Responsibility Review

Press Release

LEXINGTON, Mass., USA , March 23, 2017 /3BL Media/ – Shire plc (LSE: SHP, NASDAQ: SHPG) today announced the launch of the Company’s 2016 Annual Responsibility Review. The Review, available at, highlights how Shire’s growth has strengthened its approach to Responsibility and allows the Company to better meet the needs of people around the world with rare diseases and their families. 

Transforming Delivery of High Quality Products

Multimedia with summary

At Pfizer, we are developing innovative manufacturing techniques that better meet today’s patient needs. 

In recent years, Pfizer has made dramatic advances in our manufacturing and supply chain. In 2016, we enabled even more efficient product delivery by applying the latest technologies and innovative partnerships to our manufacturing processes and supply chain. These advances include:

· Creating a first-of-its-kind manufacturing system that will give Pfizer increased flexibility and speed of production

Pfizer Seeks to Increase Patient Access to Medicines

Multimedia with summary

In seeking to improve health around the world, we strive to make the best use of Pfizer's resources — our people, products and funding — to help build health care capacity and expand access to medicines.

Learn more at

Annual Review of CR Reporting and Comms Summit Featuring Unilever, AkzoNobel, CocaCola Enterprises & ABN Amro


The Annual Review of CR Reporting and Sustainability Communications from Ethical Corporation has just been released.
The Annual Review of is your how-to-guide on CR reporting and communications featuring insight from:
Unilever - Cofely Engie – AkzoNobel – ITV - Alcatel-Lucent – IIRC – eRevalue - Munich Airport – Hermes – Onimpact - Coca Cola Enterprises - ABN Amro – HP – Schroders - The Crown Estate – ATP - LaFarge Holcim - Nordea Bank - Junxion Strategy -  eRevalue - ArcelorMittal

Pfizer’s 2015 Annual Review Showcases Commitment to Patient Assistance

Multimedia with summary

In our 2015 Annual Review, Pfizer reflects on the programs and partnerships it engages in with the goal of improving public health worldwide. Pfizer Executive Vice President of Corporate Affairs Sally Susman talks about what it means to be committed to improving access to medicines.

Learn more about Pfizer’s patient assistance programs at

Pfizer Highlights Role of Health in Achieving the UN’s Global Goals for Sustainable Development

Multimedia with summary

In light of the recent United Nations Global Compact Leaders Summit in New York City, Pfizer reflects on the impact of health on progress toward each of the 17 Sustainable Development Goals (SDGs).

For Pfizer, harnessing the power of entrepreneurship for good strengthens our company and fulfills our purpose — to bring therapies to people that significantly improve their lives. We believe every individual deserves to lead a longer, healthier, more productive life.

Pfizer Colleagues Volunteer Skills and Expertise to Improve Public Health

Multimedia with summary

Global Health Fellows (GHF), Pfizer’s signature corporate volunteer program, allows Pfizer colleagues to use their skills and expertise to work with international development organizations to strengthen health services for people living in developing and low resource areas.

Learn more about the GHF program and Pfizer’s efforts to address complicated public health challenges around the world in our Annual Review:

Pfizer’s Progress on 2020 Reduced Water Use Goals

Multimedia with summary

Pfizer believes in the importance of reducing human impact on the environment. As part of this, we have pledged to reduce water use by 5 percent by 2020.

See Pfizer’s progress toward reduced water consumption in our 2015 Annual Review at

Pfizer’s Progress on 2020 Greenhouse Gas Emissions Goals

Multimedia with summary

In 2015, Pfizer's greenhouse gas emissions reduction goal was recognized as a Science Based Target by the initiative led by the Carbon Disclosure Project, the UN Global Compact, the World Resources Institute and World Wildlife Fund. This recognizes that Pfizer has established targets consistent with the level of decarbonization required by science to limit global warming to less than 2°C compared to pre-industrial temperatures.

For more information, visit

Pfizer's Progress on 2020 Waste Reduction Goals

Multimedia with summary

Building on the successful achievements of Pfizer’s carbon emission reduction and green chemistry programs, we are working to contribute meaningfully to global efforts to reduce human impact on the environment.

Throughout the lifecycle of our products, our aspiration is to further reduce our carbon footprint and increase energy efficiency, decrease dependence on limited resources and reduce waste in order to help ensure a sustainable future for our patients, our global community and our company.


Subscribe to annual review